Imaging breast cancer chemotherapy response with light. Commentary on Soliman et al., p. 2605.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20406838.
- Also identified by DOI 10.1158/1078-0432.CCR-10-0397 and PMC identifier 3204881.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diffuse optical spectroscopy (DOS), which is used to image tumor metabolic response to neoadjuvant chemotherapy (NAC), shows large changes in tumor functional parameters with significant reductions in oxy- and deoxyhemoglobin for responders versus nonresponders. Although investigational, DOS may provide a cost-effective, risk-free method for optimizing NAC drug and dosing strategies for individual patients.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms
- Diagnostic Imaging